Latest S-1 registration statements

Bullfrog AI Holdings files for resale of shares underlying warrants issued in recent direct offering and private placement.

La Rosa Holdings Corp. is registering the resale of up to 1,460,826 shares of its common stock by selling stockholders.

Solidion Technology, Inc. files an amendment to its Form S-1 registration statement, potentially offering up to 293,457,926 shares of common stock for resale by selling securityholders.

Beneficient files an amendment to its registration statement to register the potential resale of over 203 million shares of Class A common stock by selling holders.

Creative Medical Technology Holdings has filed a registration statement for the potential resale of up to 837,104 shares of its common stock by selling stockholders.

All Things Mobile Analytic, Inc. (ATMH) has filed a Form S-1 registration statement with the SEC for an initial public offering of 30 million shares of common stock at $0.05 per share, aiming to raise $1.5 million.

Flagfish Acquisition Corporation, a British Virgin Islands-based blank check company, has filed an S-1 registration statement for a $60 million initial public offering, with plans to target businesses connected to the Asian market.

Hennessy Capital Investment Corp. VII, a newly formed blank check company, aims to raise $150 million through an IPO to pursue a business combination in the industrial technology and energy transition sectors.

Heritage Distilling Holding Company aims to raise capital through an initial public offering and concurrent private placement to fund operations and address outstanding debt.

Connexa Sports Technologies has filed an amendment to its Form S-1 registration statement, covering the offer and sale of up to 2,200,000 shares of common stock by selling stockholders.

Thunder Power Holdings updates its registration statement for the potential sale of up to 17,616,408 shares of common stock by selling securityholders.

Venu Holding Corporation updates its IPO registration statement and secures an extension for a land purchase agreement in El Paso, Texas, signaling continued progress in its expansion plans.

Glucotrack aims to raise up to $30 million by offering common stock, pre-funded warrants, and common stock purchase warrants.

Apimeds Pharmaceuticals US, Inc. is seeking to go public to fund clinical trials for its bee venom-based therapy, Apitox, targeting osteoarthritis and multiple sclerosis symptoms.

Mullen Automotive is registering for resale up to 30 million shares of its common stock by selling stockholders, derived from convertible notes and warrants.

Cloudastructure, Inc. files an amendment to its S-1 registration statement for a direct listing of its Class A common stock on the Nasdaq Capital Market.

Natures Miracle Holding Inc. has filed a registration statement to increase the maximum aggregate offering price of its securities by $1,000,000.

Virpax Pharmaceuticals is offering up to 6,883,260 shares of common stock and pre-funded warrants in a best efforts offering to raise capital for clinical trials, working capital, and general corporate purposes.

GSR III Acquisition Corp., a blank check company, has filed an amendment to its registration statement for a $200 million initial public offering.

Drugs Made In America Acquisition Corp., a blank check company targeting the pharmaceutical industry, has filed Amendment No. 3 to its Form S-1 registration statement for a $200 million initial public offering.

Thunder Power Holdings, Inc. obtains a $350,060 promissory note from Wellen Sham with a 10% interest rate, maturing in 365 days.

Solera Corp., a leading global provider of SaaS solutions for the vehicle lifecycle ecosystem, has filed for an IPO to raise capital for debt repayment and general corporate purposes.

Stryve Foods is undertaking a public offering to sell shares of Class A Common Stock, pre-funded warrants, and common warrants to raise capital for working capital and general corporate purposes.

DarkPulse is set to acquire key assets from the liquidated Optilan (UK) Limited while simultaneously filing an S-1 amendment to register shares for a $30 million equity financing agreement with GHS Investments LLC.

Artius II Acquisition Inc., a blank check company, has filed an S-1 registration statement for a $200 million IPO, aiming to pursue a business combination with a technology-focused company.

Alpha Cognition USA Inc. enters into an employment agreement with Henry Du as VP, Finance and Accounting, while the company prepares for a public offering.

Sonnet BioTherapeutics plans to offer common stock and warrants to purchase common stock, aiming to raise capital for research and development, working capital, and debt repayment.

Natures Miracle Holding Inc. plans to offer up to 25,746,653 units, each with common stock and warrants, and register 3,317,400 shares for resale by selling stockholders.

Wellgistics Health, a holding company focused on pharmaceuticals and healthcare services, has filed an S-1/A form with the SEC to register shares of its common stock for an initial public offering, with plans to list on the Nasdaq Capital Market under the symbol 'WGRX'.

Health In Tech, Inc. has filed Amendment No. 4 to its Form S-1 registration statement for a proposed IPO of 2,300,000 shares of Class A Common Stock and the potential resale of 1,969,585 shares by a selling shareholder.